The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

A non-ST segment elevation myocardial infarction, also called an NSTEMI or a non-STEMI, is a type of heart attack. While it's often less damaging to your heart than a STEMI, it's still a serious ...

Cardiac intensive care units are specialized, high-acuity, and resource-intensive environments for the care of critically ill ...

Use of the Impella CP microaxial flow pump plus a 30-minute delay to coronary angioplasty did not significantly reduce heart damage compared with no left ventricular (LV) support in patients with ...

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...

Myocardial infarction, commonly known as a heart attack, is one of the most serious heart problems people can face. It happens when blood flow to a part of the heart muscle is suddenly blocked.

Electrocardiography is performed in the emergency department to test for myocardial infarction. Image courtesy of Harrington et al. A 56-year-old woman presents to a rural emergency department with ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...